Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R HENZE

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American Chemical Society|March 19, 2010
Certain 5-phenyl-5-(substituted phenyl)-hydantoinsJ W MELTON, H R HENZE
The Journal of Organic Chemistry|March 19, 2010
Certain 1-naphthyl ketonesL G NUNN, H R HENZE
The Journal of Organic Chemistry|March 19, 2010
Certain 5-(1-naphthyl)-5-substituted hydantoinsH R HENZE, L G NUNN
Journal of the American Chemical Society|March 19, 2010
Pyrrole formation during attempted hydantoin synthesisH R HENZE, J H SHOWN
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study GroupPeter Bader, Hermann Kreyenberg, Günter H R Henze, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American Chemical Society|March 19, 2010
Certain 5-phenyl-5-(substituted phenyl)-hydantoinsJ W MELTON, H R HENZE
The Journal of Organic Chemistry|March 19, 2010
Certain 1-naphthyl ketonesL G NUNN, H R HENZE
The Journal of Organic Chemistry|March 19, 2010
Certain 5-(1-naphthyl)-5-substituted hydantoinsH R HENZE, L G NUNN
Journal of the American Chemical Society|March 19, 2010
Pyrrole formation during attempted hydantoin synthesisH R HENZE, J H SHOWN
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 10, 2008
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study GroupPeter Bader, Hermann Kreyenberg, Günter H R Henze, et al.
Pageof 1